Jacqueline Bräutigam

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Jacqueline Bräutigam is an author at Goethe University Frankfurt specializing in cell signaling, vascular endothelial growth factor inhibition, and endothelial activation.

Publications per year

2018–2019

Publications

Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2

Jacqueline Bräutigam, Iris Bischoff, Christoph Schürmann et al. · Journal of Molecular and Cellular Cardiology · 2019 · 30 citations

Medicine, Molecular Medicine, Pharmacotherapy +14

Narciclasine exerts anti‐inflammatory actions by blocking leukocyte–endothelial cell interactions and down‐regulation of the endothelial TNF receptor 1

Rebecca Schwenk, Gesine Wack, Gabriele Zuchtriegel et al. · The FASEB Journal · 2019 · 28 citations

Life Sciences, Immunology, Pharmacology +17

The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen

Betty Luong, Rebecca Schwenk, Jacqueline Bräutigam et al. · PLoS ONE · 2018 · 10 citations · Full text

Life Sciences, Oncology, Pharmacology +17

1–3 of 3